rectal-cancer

Documents about rectal-cancer

• Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)#968314ClinicalTrials.gov
• Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer#851696ClinicalTrials.gov
• The San Francisco Cancer Initiative: A Community Effort To Reduce The Population Burden Of Cancer#614601eScholarship
• Insights into Food Intake, Overall Diet Quality, and Stool Short-Chain Fatty Acids during Treatment for Rectal Cancer: A Pilot Study.#9416NCBI PubMed Central
• Tumor Resectability and Pathologic Response After Neoadjuvant Long-Course Chemoradiotherapy for Locally Advanced Rectal Cancer in a Resource-Limited Setting#135514Unpaywall
• Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: Comparison to fecal occult stool blood test#153476PMC Full-Text (OAI)
• Deconstructing Risk: A Machine Learning-Guided Logistic Regression Model for Predicting Early Mucosal Edema Following Prophylactic Ileostomy in Elderly Rectal Cancer Patients.#823528NCBI PubMed Central
• A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum#891087ClinicalTrials.gov
• p53 and Response to Preoperative Radiotherapy for T2 and T3#911297ClinicalTrials.gov
• Outcomes of Colonoscopy With Non-anesthesiologist Administered Propofol#969999ClinicalTrials.gov
• Treatment of "Low Anterior Resection Syndrome" by Percutaneous Nerve Evaluation and Transanal Irrigation#1047627ClinicalTrials.gov
• Impact of Obesity on Textbook Outcome Achievement in Minimally Invasive Colorectal Cancer Surgery#811608ClinicalTrials.gov
• Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection#918798ClinicalTrials.gov
• A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)#417527ClinicalTrials.gov
• Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study#181777ClinicalTrials.gov
• Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I#374458HAL (France)
• MRI-Based Radiomics and Machine Learning for Predicting Pathological Tumor Invasion and Nodal Status in Rectal Cancer: A Retrospective Study#680443Repositorio Institucional de la Universidad de Granada
• Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer#162449ClinicalTrials.gov
• SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)#1031685ClinicalTrials.gov
• Reducing Low Anterior Resection Syndrome After Low Rectal Cancer Surgery Using an Integrated Intra-Anal Balloon Training and Reminder Device: Feasibility Nonrandomized Controlled Trial.#168107NCBI PubMed Central
• Understanding and Tailored Treatment of Low Anterior Resection Syndrome#873689ClinicalTrials.gov
• Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)#903357ClinicalTrials.gov
• Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay#904939ClinicalTrials.gov
• Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model#801999ClinicalTrials.gov
• MRI to guide clinical management of rectal cancer: updated consensus recommendations from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR)—PART I primary staging#147556HAL (France)
• Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy#888773ClinicalTrials.gov
• Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer#411393ClinicalTrials.gov
• Enterohepatic Cycle Mimicking a Digestive Foreign Body after Surgery for Locally Advanced Rectal Cancer: A Case Report#427350HAL (France)
• Supplemental Material for: Radiologic progression of disease during neoadjuvant dostarlimab in dMMR Lynch-associated locally advanced rectal cancer resulting in pathologic complete response: a Case Report.#445383Figshare
• The Impact of AI-Assisted Nursing Care Intervention Within the Enhanced Recovery Framework on Outcomes of Colorectal Surgery Patients#826017ClinicalTrials.gov
• PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer#896055ClinicalTrials.gov
• Rectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, and GRECCAR)#26295HAL (France)
• Development and validation of web-based prediction models for major low anterior resection syndrome at 3 and 6 months after sphincter-preserving surgery in patients with rectal cancer.#327265NCBI PubMed Central
• ‘French LARS score’: validation of the French version of the low anterior resection syndrome (LARS) score for measuring bowel dysfunction after sphincter-preserving surgery among rectal cancer patients: a study protocol#311885HAL (France)
• Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC#332760ClinicalTrials.gov
• THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy#913877ClinicalTrials.gov
• The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)#454019ClinicalTrials.gov
• Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma#849866ClinicalTrials.gov
• Rektum kanseri nedeniyle küratif amaçlı aşağı anterior rezeksiyon ve abdominoperineal rezeksiyon yapılan hastaların lokal nüks, uzak metastaz ve sağ kalım açısından karşılaştırılması#1038191DSpace at Dokuz Eylul University
• Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer#814598eScholarship
• Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.#867058ClinicalTrials.gov
• Sparing sphincters and laparoscopic resection improve survival by optimizing the circumferential resection margin in rectal cancer patients#934606Koc University Digital Collections
• Tumour cell density quantified by artificial intelligence is associated with differential benefit from irinotecan-based chemo-radiotherapy in locally advanced rectal cancer: a post-hoc study of the phase 3 ARISTOTLE trial.#458661NCBI PubMed Central
• Contact radiotherapy using a 50kV X-ray system: Evaluation of relative dose distribution with the Monte Carlo code PENELOPE and comparison with measurements#340059HAL (France)
• Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopic Resection: a Time-to-event Cohort Study#835873ClinicalTrials.gov
• Interactive Online Informational and Peer Support App for Patients with Low Anterior Resection Syndrome#872117ClinicalTrials.gov
• Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases#934568Koc University Digital Collections
• A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)#842721ClinicalTrials.gov
• A prospective RCT comparing combined chromoendoscopy with water exchange (CWE) vs water exchange (WE) vs air insufflation (AI) in adenoma detection in screening colonoscopy#620185eScholarship
• Unmet social needs and colorectal cancer testing at 45-49 since the 2021 USPSTF recommendation#683846eScholarship